In breast cancer cells, XIST has anti-cancer effects by regulating miR-454 or miR-362-5p, which inhibit cell proliferation and epithelial-mesenchymal transition (EMT), while also inducing apoptosis (28, 29). Here, XIST is linked to cancer.